Loading insider details...
Beta
Latest Form 4 (Oct 15, 2026): Grant/Award of 38,000 IBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | iBio, Inc. (IBIO) | Grant/Award | 38,000 | n/a |
| Sep 18, 2026 | SAB Biotherapeutics, Inc. (SABS) | Tax Withholding | 473 | n/a |
| Jun 26, 2026 | SAB Biotherapeutics, Inc. (SABS) | Tax Withholding | 988 | n/a |
| Mar 25, 2026 | SAB Biotherapeutics, Inc. (SABS) | Tax Withholding | 988 | n/a |
| Feb 5, 2026 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 2,400,000 | n/a |
| Dec 12, 2025 | SAB Biotherapeutics, Inc. (SABS) | Tax Withholding | 988 | n/a |
| Nov 24, 2025 | iBio, Inc. (IBIO) | Grant/Award | 13,500 | n/a |
| Sep 22, 2025 | SAB Biotherapeutics, Inc. (SABS) | Tax Withholding | 1,977 | n/a |
| Aug 28, 2025 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 2,400,000 | n/a |
| Apr 1, 2025 | SAB Biotherapeutics, Inc. (SABS) | Tax Withholding | 1,179 | n/a |